View in EDS HTML Full Text PDF Full Text

Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance.

Saved in:
Bibliographic Details
Title: Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance.
Authors: Dolan M; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America., Mastri M; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America., Tracz A; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America., Christensen JG; Mirati Therapeutics, San Diego, California, United States of America., Chatta G; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America., Ebos JML; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America.; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America.
Source: PloS one [PLoS One] 2019 Aug 01; Vol. 14 (8), pp. e0220101. Date of Electronic Publication: 2019 Aug 01 (Print Publication: 2019).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31369645
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dolan+M%22">Dolan M</searchLink>; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Mastri+M%22">Mastri M</searchLink>; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Tracz+A%22">Tracz A</searchLink>; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Christensen+JG%22">Christensen JG</searchLink>; Mirati Therapeutics, San Diego, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Chatta+G%22">Chatta G</searchLink>; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Ebos+JML%22">Ebos JML</searchLink>; Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America.; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2019 Aug 01; Vol. 14 (8), pp. e0220101. <i>Date of Electronic Publication: </i>2019 Aug 01 (<i>Print Publication: </i>2019).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31369645
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0220101
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0220101
    Titles:
      – TitleFull: Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dolan M
      – PersonEntity:
          Name:
            NameFull: Mastri M
      – PersonEntity:
          Name:
            NameFull: Tracz A
      – PersonEntity:
          Name:
            NameFull: Christensen JG
      – PersonEntity:
          Name:
            NameFull: Chatta G
      – PersonEntity:
          Name:
            NameFull: Ebos JML
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2019 Aug 01
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1932-6203
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: PloS one
              Type: main
ResultId 1